Departments of Surgery, Medical University of Vienna, Vienna, Austria.
Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Dig Endosc. 2018 Mar;30(2):212-218. doi: 10.1111/den.12959. Epub 2017 Oct 3.
Symptomatic cervical heterotopic gastric mucosa, also known as cervical inlet patch (CIP), may present in various shapes and causes laryngopharyngeal reflux (LPR). Unfortunately, argon plasma coagulation, standard treatment of small symptomatic CIP, is limited in large CIP mainly because of concerns of stricture formation. Therefore, we aimed to investigate radiofrequency ablation (RFA), a novel minimally invasive ablation method, in the treatment of CIP focusing on large symptomatic patches.
Consecutive patients with macroscopic and histological evidence of large (≥20 mm diameter) heterotopic gastric mucosa were included in this prospective trial. Primary outcome was complete macroscopic and histological eradication rate of CIP. Secondary outcome measures were symptom improvement, quality of life, severity of LPR and adverse events.
Ten patients (females, n = 5) underwent RFA of symptomatic CIP. Complete histological and macroscopic eradication of CIP was observed in 80% (females, n = 4) of individuals after two ablations. Globus sensations significantly improved from median visual analog scale score 8 (5-9) at baseline to 1.5 (1-7) after first ablation and 1 (1-2) after final evaluation (P < 0.001). Mental health scores significantly increased from 41.4 (± 8.5) to 54.4 (± 4.4) after RFA (P = 0.007). LPR improved significantly (P = 0.005) with absence of strictures after a mean follow up of 1.9 (± 0.5) years.
This is the first study on RFA focusing on therapy of large symptomatic heterotopic gastric mucosa. Hereby, we demonstrate that this new technique can be successfully implemented in patients where treatment was limited so far (NCT03023280).
有症状的颈部异位胃黏膜,又称食管入口斑(CIP),可能有各种形态,可引起咽喉反流(LPR)。遗憾的是,氩等离子凝固术是治疗小症状性 CIP 的标准方法,但对于较大的 CIP 主要受到形成狭窄的顾虑限制。因此,我们旨在研究射频消融(RFA),一种新的微创消融方法,治疗大的(≥20mm 直径)症状性 CIP。
本前瞻性试验纳入有大(≥20mm 直径)异位胃黏膜的宏观和组织学证据的连续患者。主要结局是 CIP 的完全宏观和组织学消除率。次要结局指标是症状改善、生活质量、LPR 严重程度和不良事件。
10 例(女性 n=5)患者接受了症状性 CIP 的 RFA。2 次消融后,80%(女性 n=4)患者的 CIP 完全组织学和宏观消除。胃食管反流病的视觉模拟量表评分从基线时的中位数 8(5-9)降至首次消融后的 1.5(1-7)和最终评估后的 1(1-2)(P<0.001)。心理健康评分从 RFA 前的 41.4(±8.5)显著增加至 54.4(±4.4)(P=0.007)。在平均 1.9(±0.5)年的随访中,LPR 显著改善(P=0.005),且无狭窄。
这是第一项关于 RFA 治疗大症状性异位胃黏膜的研究。在此,我们证明该新技术可成功应用于目前治疗受限的患者(NCT03023280)。